Loading clinical trials...
Loading clinical trials...
Devic's neuromyelitis optica (NMO) is rare. Epidemiological and demographic data are poor, based mainly on monocentric cohorts. Moreover, NMO might be difficult to distinguish from multiple sclerosis ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hospices Civils de Lyon
NCT06620809 · Neuromyelitis Optica Spectrum Disorders
NCT07202494 · Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and more
NCT06413654 · Neuromyelitis Optica Spectrum Disorders
NCT05730699 · Neuromyelitis Optica Spectrum Disorders
NCT06485232 · Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized, and more
Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
Bron
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions